"10.1371_journal.pone.0099453","plos one","2014-06-09T00:00:00Z","Shomi Oka; Hiroshi Furukawa; Aya Kawasaki; Kota Shimada; Shoji Sugii; Atsushi Hashimoto; Akiko Komiya; Naoshi Fukui; Satoshi Ito; Tadashi Nakamura; Koichiro Saisho; Masao Katayama; Shinichiro Tsunoda; Hajime Sano; Kiyoshi Migita; Akiko Suda; Shouhei Nagaoka; Naoyuki Tsuchiya; Shigeto Tohma","Clinical Research Center for Allergy and Rheumatology, Sagamihara Hospital, National Hospital Organization, Sagamihara, Japan; Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan; Department of Rheumatology, Sagamihara Hospital, National Hospital Organization, Sagamihara, Japan; Department of Rheumatology, Tokyo Metropolitan Tama Medical Center, Fuchu, Japan; Department of Rheumatology, Niigata Rheumatic Center, Shibata, Japan; Department of Rheumatology, Kumamoto Shinto General Hospital, Kumamoto, Japan; Department of Orthopedics/Rheumatology, Miyakonojo Hospital, National Hospital Organization, Miyakonojo, Japan; Department of Internal Medicine, Nagoya Medical Center, National Hospital Organization, Nagoya, Japan; Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan; Clinical Research Center, Nagasaki Medical Center, National Hospital Organization, Omura, Japan; Department of Rheumatology, Yokohama Minami Kyosai Hospital, Yokohama, Japan; Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama, Japan","Conceived and designed the experiments: HF NT S. Tohma. Performed the experiments: SO HF A. Kawasaki. Contributed reagents/materials/analysis tools: HF K. Shimada SS AH A. Komiya NF SI TN K. Saisho MK S. Tsunoda HS KM AS SN NT S. Tohma. Contributed to the writing of the manuscript: SO HF NT S. Tohma.","HF has the following conflicts: The following funders are supported in whole or in part by the indicated pharmaceutical companies. The Japan Research Foundation for Clinical Pharmacology is run by Daiichi Sankyo, the Takeda Science Foundation is supported by an endowment from Takeda Pharmaceutical Company and the Nakatomi Foundation was established by Hisamitsu Pharmaceutical Co., Inc. The Daiwa Securities Health Foundation was established by Daiwa Securities Group Inc. and Mitsui Sumitomo Insurance Welfare Foundation was established by Mitsui Sumitomo Insurance Co., Ltd. AH was supported by research grants from Mitsubishi Tanabe Pharma Corporation. NT is supported by SENSHIN Medical Research Foundation, which is supported by an endowment from Mitsubishi Tanabe Pharma Corporation. ST was supported by research grants from 9 pharmaceutical companies: Abbott Japan Co., Ltd., Astellas Pharma Inc., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Merck Sharp and Dohme Inc., Pfizer Japan Inc., Takeda Pharmaceutical Company Limited, Teijin Pharma Limited. The other authors declare no financial or commercial conflict of interest. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","06","Shomi Oka","SO",19,TRUE,3,3,NA,NA,TRUE,FALSE,TRUE,2,"8;10",TRUE
